IRB Oversight: HHS’ Registration Practices, Firms Conduct To Face Greater Scrutiny
Hearing in House may boost prospects of legislation that would impose new requirements on the initial approval of clinical trials.
Hearing in House may boost prospects of legislation that would impose new requirements on the initial approval of clinical trials.